CARDIOMETABOLIC HEALTH CONGRESS
Interventional Cardiology
CME/CE Activities
News Digest
Cardiometabolic Health Congress (CMHC) Launches Focused Digital Education Hubs
Cardiometabolic health education leader CMHC announced that its digital education has been streamlined into 12 hubs organized by therapeutic or clinical topics for focused learning
Cardiometabolic Health Congress Hosts 2023 Women’s Masterclass in California
In August 2023, Cardiometabolic Health Congress will host the annual Women’s Cardiometabolic Health and Wellness Masterclass at the Laguna Cliffs Marriott Resort & Spa Informed
Abstracts Published from the 17th Annual Cardiometabolic Health Congress
Abstracts presented on topics in cardiorenal and cardiometabolic health at the 17th Annual Cardiometabolic Health Congress (CMHC) conference in Boston have been published in Postgraduate Medicine.
2022 FDA-Approved Cardiometabolic Drugs and Devices
Although the U.S. Food and Drug Administration (FDA) approved a record-low number of drugs and devices from January through September 2022, many of those were
Aortic Stenosis: Updated Guidelines for Diagnosis and Management
By Kate Buron In December 2020 the Joint Committee on Clinical Practice Guidelines, a combined effort from the American College of Cardiology (ACC) and the
CardioMEMS Shows Promise for Expanded Use Despite Falling Short in Trial
By Kate Buron When The U.S. Food and Drug Administration (FDA) approved the CardioMEMS HF System in 2014, Abbott harnessed the power of artificial intelligence
Day 4 Nightly News: 18th Annual CMHC
On Saturday, Oct. 21, 2023, Cardiometabolic Health Congress (CMHC) celebrated the final day of its 18th Annual Conference, Social Determinants and Digital Advances in Cardiorenal
Day 3 Nightly News: 18th Annual CMHC
The third day of Social Determinants and Digital Advances in Cardiorenal Metabolic Health, the 18th Annual Cardiometabolic Health Congress (CMHC), delivered insights on selecting and
Day 2 Nightly News: 18th Annual CMHC
The cardiorenal metabolic education continued on Thursday, Oct. 19, 2023, when the 18th Annual Cardiometabolic Health Congress (CMHC) launched its second day of sessions at
Day 1 Preconference Nightly News: 18th Annual CMHC
On Wednesday, Oct. 18, 2023, Cardiometabolic Health Congress (CMHC) returned to the Boston Park Plaza for the 18th Annual Conference, Social Determinants and Digital Advances
10 Cardiorenal Stories to Watch
The experts behind Cardiometabolic Health Congress have identified 10 stories in cardiorenal medicine to watch in 2023.
2022 News in Review: Top 10 Stories in Cardiorenal Metabolic Health
The experts at Cardiometabolic Health Congress (CMHC) have selected the TOP 10 developments, approvals, news, and findings from 2022 that impact the field of cardiorenal
Finerenone Improves Outcomes in CVD and CKD
Recent findings from FIDELITY-HF support the use of finerenone and highlight the importance of routine screening for renal function in primary care to identify kidney
Dr. Bakris and CMHC from the AHA’s Scientific Sessions
The Cardiometabolic Health Congress (CMHC) was pleased to be present at the American Heart Association’s Scientific Sessions at the McCormick Place Convention Center in Chicago
Expert Highlights and Perspectives
Watch Dr. Angela Lowenstern cover important updates in the screening, diagnosis, and risk stratification of women with AS, as well as practical considerations for TAVR from the 2023 Women’s Health Masterclass, recorded August 19, 2023.
Resources
Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association
2020 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation
2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation